Publication | Open Access
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma
231
Citations
22
References
2010
Year
Intravenous methotrexate can be safely administered concurrently with R-CHOP and is associated with a low risk of CNS recurrence in high-risk patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1